2-Methyl-6-(trifluoromethyl)nicotinaldehyde, 95.0%, 250mg

1-(2-methylphenyl)-1,4-diazepane acetate, 95.0%, 5g

(S)-(4-Benzylmorpholin-2-yl)methanol, 97%, 1g

Tert-butyl (R)-1-(chloromethyl)-5-hydroxy-1,2-dihydro-3H-benzo[e]indole-3-carboxylate, 97%, 50mg

Nitromethane D3, 99 at%D, 10 ml, glass packaging

(t-Bu)PhCPhos Pd G3, 98.0%, 100mg

Diethyl (S)-(2-((4-((3-chloro-4-fluorophenyl)amino)-7-((tetrahydrofuran-3-yl)oxy)quinazolin-6-yl)amino)-2-oxoethyl)phosphonate, 98%, 1g

(3R,4S)-4-(4-(Benzyloxy)phenyl)-1-(4-fluorophenyl)-3-(3-(4-fluorophenyl)-3-oxopropyl)azetidin-2-one, 98%, 5g

TRANS (+/-) [4-(TRIFLUOROMETHYL)PYRROLIDINE]-1,3-DICARBOXYLIC ACID 1-TERT-BUTYL ESTER, 95.0%, 500mg

5-Bromoimidazo[1,2-a]pyridine-2-carboxylic acid, 95.0%, 5g

2-(Methylsulfonyl)isonicotinaldehyde, 97.0%, 100mg

2-Chloroquinoxaline, 97.0%, 10g

3-Iodo-4,5-dimethyl-1H-pyrazole, 97%, 5g